PubMed

Semi-allogeneic vaccine for T-cell lymphoma.

Yu J, Kindy MS, Gattoni-Celli S.

J Transl Med. 2007 Aug 8;5:39.PMID: 17686178 [PubMed - indexed for MEDLINE]Related articlesFree article

Semi-allogeneic vaccines and tumor-induced immune tolerance.

Yu J, Kindy MS, Gattoni-Celli S.

J Transl Med. 2009 Jan 8;7:3.PMID: 19133135 [PubMed - indexed for MEDLINE]Related articlesFree article

Superior anti-tumor protection and therapeutic efficacy of vaccination with allogeneic and semiallogeneic dendritic cell/tumor cell fusion hybrids for murine colon adenocarcinoma.

Yasuda T, Kamigaki T, Kawasaki K, Nakamura T, Yamamoto M, Kanemitsu K, Takase S, Kuroda D, Kim Y, Ajiki T, Kuroda Y.

Cancer Immunol Immunother. 2007 Jul;56(7):1025-36. Epub 2006 Nov 28.PMID: 17131118 [PubMed - indexed for MEDLINE]Related articles

[Allogeneic dendritic cell vaccine pulsed with heat shocked tumor cell lysate can enhance antitumor immunity]

You J, Wang CL, Hao XS.

Zhonghua Yi Xue Za Zhi. 2007 Oct 23;87(39):2785-90. Chinese. PMID: 18167273 [PubMed - indexed for MEDLINE]Related articles

Vaccination with allogeneic GM-CSF gene-modified lung cancer cells: antitumor activity comparing with that induced by autologous vaccine.

Li H, Jiang HJ, Ma MQ, Wei F, An XM, Ren XB.

Cancer Biother Radiopharm. 2007 Dec;22(6):790-8.PMID: 18158770 [PubMed - indexed for MEDLINE]Related articles

Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.

Li B, Simmons A, Du T, Lin C, Moskalenko M, Gonzalez-Edick M, VanRoey M, Jooss K.

Clin Immunol. 2009 Nov;133(2):184-97. Epub 2009 Aug 7.PMID: 19664962 [PubMed - indexed for MEDLINE]Related articles

Optimization of intracerebral tumour protection by active-specific immunization against murine melanoma B16/G3.12.

Staib L, Harel W, Mitchell MS.

Melanoma Res. 2001 Aug;11(4):325-35.PMID: 11479420 [PubMed - indexed for MEDLINE]Related articles

Cross-reactions between tumor cells and allogeneic normal tissues. Inhibition of a syngeneic lymphoma outgrowth in H-2 and non-H-2 alloimmune BALB/c mice.

Parmiani G, Sensi ML, Carbone G, Colombo M, Pierotti M, Ballinari D, Hilgers J, Hilkens J.

Int J Cancer. 1982 Mar 15;29(3):323-32.PMID: 7068280 [PubMed - indexed for MEDLINE]Related articles

Specific antitumor effects of tumor vaccine produced by autologous dendritic cells transfected with allogeneic osteosarcoma total RNA through electroporation in rats.

Yu Z, Sun H, Zhang T, Yang T, Long H, Ma B.

Cancer Biol Ther. 2009 May;8(10):973-80. Epub 2009 May 24.PMID: 19287216 [PubMed - indexed for MEDLINE]Related articles

Electrofusion of syngeneic dendritic cells and tumor generates potent therapeutic vaccine.

Kjaergaard J, Shimizu K, Shu S.

Cell Immunol. 2003 Oct;225(2):65-74.PMID: 14698141 [PubMed - indexed for MEDLINE]Related articles

Interleukin-2 gene-modified allogeneic melanoma cell vaccines can induce cross-protection against syngeneic tumors in mice.

Kircheis R, Küpcü Z, Wallner G, Rössler V, Schweighoffer T, Wagner E.

Cancer Gene Ther. 2000 Jun;7(6):870-8.PMID: 10880017 [PubMed - indexed for MEDLINE]Related articlesFree article

Growth and metastasis in allogeneic hosts. Lack of H-2-negative or somatic hybrid variant selection.

De Giovanni C, Lollini PL, Nicoletti G, Del Re B, Scotlandi K, Prodi G, Nanni P.

Exp Clin Immunogenet. 1987;4(3):153-62.PMID: 3273420 [PubMed - indexed for MEDLINE]Related articles

Complete rejection of a T-cell lymphoma due to synergism of T-cell receptor costimulatory molecules, CD80, CD40L, and CD40.

Ruybal P, Gravisaco MJ, Barcala V, Escalada A, Di Sciullo P, Waldner C, Mongini C.

Vaccine. 2008 Jan 30;26(5):697-705. Epub 2007 Dec 3.PMID: 18155328 [PubMed - indexed for MEDLINE]Related articles

Autologous versus allogeneic peptide-pulsed dendritic cells for anti-tumour vaccination: expression of allogeneic MHC supports activation of antigen specific T cells, but impairs early naïve cytotoxic priming and anti-tumour therapy.

Merrick A, Diaz RM, O'Donnell D, Selby P, Vile R, Melcher A.

Cancer Immunol Immunother. 2008 Jun;57(6):897-906. Epub 2007 Dec 4.PMID: 18057935 [PubMed - indexed for MEDLINE]Related articles

Immunogenicity of dendritic-tumor fusion hybrids and their utility in cancer immunotherapy.

Shu S, Zheng R, Lee WT, Cohen PA.

Crit Rev Immunol. 2007;27(5):463-83. Review.PMID: 18197808 [PubMed - indexed for MEDLINE]Related articles

Immunotherapeutic efficacy of vaccines generated by fusion of dendritic cells and HPV16-associated tumour cells.

Símová J, Bubeník J, Bieblová J, Indrová M, Jandlová T.

Folia Biol (Praha). 2005;51(1):19-24.PMID: 15783088 [PubMed - indexed for MEDLINE]Related articlesFree article

An allogeneic hybrid-cell fusion vaccine against canine mammary cancer.

Bird RC, Deinnocentes P, Lenz S, Thacker EE, Curiel DT, Smith BF.

Vet Immunol Immunopathol. 2008 Jun 15;123(3-4):289-304. Epub 2008 Feb 26.PMID: 18423623 [PubMed - indexed for MEDLINE]Related articles

In vivo anti-tumor effect of hybrid vaccine of dendritic cells and esophageal carcinoma cells on esophageal carcinoma cell line 109 in mice with severe combined immune deficiency.

Guo GH, Chen SZ, Yu J, Zhang J, Luo LL, Xie LH, Su ZJ, Dong HM, Xu H, Wu LB.

World J Gastroenterol. 2008 Feb 28;14(8):1167-74.PMID: 18300341 [PubMed - indexed for MEDLINE]Related articlesFree article

The biological effects of syngeneic and allogeneic cytokine-expressing prophylactic whole cell vaccines and the influence of irradiation in a murine melanoma model.

Labarthe MC, Halanek N, Birchall L, Russell N, Desel C, Todryk S, Peters MJ, Lucas A, Falkenberg FW, Dalgleish AG, Whelan M, Ward SJ.

Cancer Immunol Immunother. 2006 Mar;55(3):277-88. Epub 2005 Sep 13.PMID: 16158275 [PubMed - indexed for MEDLINE]Related articles

Bone marrow-derived dendritic cells pulsed with tumor lysates induce anti-tumor immunity against gastric cancer ex vivo.

Li YL, Wu YG, Wang YQ, Li Z, Wang RC, Wang L, Zhang YY.

World J Gastroenterol. 2008 Dec 14;14(46):7127-32.PMID: 19084922 [PubMed - indexed for MEDLINE]Related articlesFree article